Adelaide BioMed City | Health Innovation and Translation District
Adelaide BioMed City (ABMC) Innovation District, is a $3.8B Health and Medical Innovation District in the heart of Adelaide, comprised of leading-edge anchor institutes and companies, that cluster and connect with start-ups, business incubators and accelerators.
It offers mixed-use infrastructure where researchers, clinicians and students work together with entrepreneurs and leading industry players.
ABMC aspires for global significance through high impact translational research, that when commercialised drives positive tangible health care improvements nationally and internationally.
By 2030 ABMC will be a globally significant Health Innovation and Translation District.
To deliver health and economic impact, locally and globally. Accelerating health innovation and translation, by acting as a gateway for industry-research collaboration, and a catalyst for research commercialisation.